Mainland Chinese technology firms have turned to Hong Kong as their primary fundraising and launch venue, raising record capital in 2026.
This shift signals a strategic pivot in how Chinese AI startups, chipmakers, and robotics companies access global markets. By utilizing the Hong Kong Stock Exchange, these firms can leverage the city's liquidity and market reforms to scale operations while remaining close to mainland hubs.
Chinese tech firms raised HK$212.75 billion ($27.13 billion) in 2026 [1]. This surge includes contributions from Apple suppliers and rivals to OpenAI. The first half of 2026 marked the busiest start for initial public offerings in Hong Kong in five years [3].
Among the notable listings was Insilico Medicine, which raised HK$2.28 billion ($291 million) during its IPO [2]. The influx of capital is supported by a broader push from Chinese leadership to accelerate artificial intelligence development.
Finance Chief Paul Chan said Hong Kong should serve as a hub for the commercialisation of artificial intelligence and as a strategic base for mainland Chinese AI companies' overseas expansion.
The city's appeal is growing as an alternative to Western markets. An unnamed Goldman Sachs banker said Hong Kong is as good as Wall Street for Chinese tech firms.
Officials point to several factors driving this trend, including recent market reforms and the city's role as a bridge for commercialization. These elements make the region an attractive venue for firms seeking to transition from research and development to global commercial scale.
“Hong Kong is as good as Wall Street for Chinese tech firms.”
The migration of Chinese tech listings to Hong Kong reflects a broader geopolitical and economic strategy to reduce reliance on U.S. capital markets. By establishing a dominant financial hub for AI and robotics in Hong Kong, Beijing and Hong Kong officials are creating a controlled environment for overseas expansion that aligns with national strategic goals while maintaining access to international investors.
